Physician

Rizwan Shaikh, M.D.

According to 2025 Medicare claims, Rizwan Shaikh, M.D. (NPI: 1154736791) practices ophthalmology in the Albuquerque, NM market, with the plurality of this provider's patient population coming from Bernalillo, NM. This provider's primary affiliated billing organization is EYE ASSOCIATES OF NEW MEXICO LTD (NPI: 1104868520; TIN: 85-0246856) and primary practice location at 87109-5857.

Shaikh's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,038 traditional Medicare patients, billed 47,562 HCPCS/CPT codes, and received $3,121,898 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 723 prescription claims across 208 beneficiaries totaling $32,559 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 7 records totaling $305. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $12,118 to $3,121,898. Similarly, Part D prescription costs have moved sharply higher in recent years, from $19,170 to $32,559. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.6M$3.1M2019 Medicare payment: $12,118 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $36,297 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $657,842 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,931,597 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,225,604 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,121,898 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019100175$12,118
2020171492$36,297
20215342,439$657,842
20229758,346$1,931,597
20231,00222,343$2,225,604
20241,03847,562$3,121,898

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$19K$37K2015 Drug cost: $19,170 (USD; Tot_Drug_Cst)2016 Drug cost: $8,680 (USD; Tot_Drug_Cst)2017 Drug cost: $2,324 (USD; Tot_Drug_Cst)2018 Drug cost: $607 (USD; Tot_Drug_Cst)2019 Drug cost: $2,857 (USD; Tot_Drug_Cst)2020 Drug cost: $4,605 (USD; Tot_Drug_Cst)2021 Drug cost: $17,854 (USD; Tot_Drug_Cst)2022 Drug cost: $24,346 (USD; Tot_Drug_Cst)2023 Drug cost: $37,048 (USD; Tot_Drug_Cst)2024 Drug cost: $32,559 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201523115$19,170
20161995$8,680
2017N/R19$2,324
2018N/R16$607
20192659$2,857
20203270$4,605
202177197$17,854
2022169475$24,346
2023205606$37,048
2024208723$32,559

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye6341,651$85
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more267295$68
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more405561$58
J2777Injection, faricimab-svoa, 0.1 mg26239,000$27
92134Imaging of retina7041,252$26

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate2296,514$6,681
IlevroNepafenac12317$4,795
DifluprednateDifluprednate22498$1,918
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat815,593$1,355
Ketorolac TromethamineKetorolac Tromethamine571,337$1,100

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.7$305Alcon Vision LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Rizwan Shaikh, M.D.?

Tedicare shows public-source Medicare data for Rizwan Shaikh, M.D. (NPI 1154736791), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rizwan Shaikh, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Rizwan Shaikh, M.D.?

Rizwan Shaikh, M.D. is linked to EYE ASSOCIATES OF NEW MEXICO LTD (billing NPI 1104868520) in the available physician profile data.

Does Rizwan Shaikh, M.D. have Open Payments data?

Rizwan Shaikh, M.D. has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.